We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Estrogen Testing Methods Need Improving

By LabMedica International staff writers
Posted on 20 Mar 2013
All methods for measuring estrogens, which plays such crucial role in human biology, should be made traceable to a common standard.

The estrogen hormones have a significant impact on the health of the skin, blood vessels, bones, muscle, kidney, liver, digestive system, brain, lung and pancreas and studies have linked changes in estradiol levels to coronary artery disease, stroke and breast cancer. More...


Scientists from The Endocrine Society (Chevy Chase, MD, USA) have put forward a position paper that identified a number of issues with the current testing methods used for a typical patient's care. Most of the tests used in the clinical setting cannot detect the low estradiol (E2) concentrations found in men, children, menopausal women, and breast cancer patients taking drugs that decrease estradiol levels. In addition, other compounds in the body can interfere with the testing, leading to results that can be 10 times the true estradiol level.

Most methods used in patient care measure E2 directly, without prior isolation from serum, are enzyme-based immunoassays. A survey on instruments for the automated immunoassay of E2 lists 28 different assay platforms from eight different companies. New methods, like the original mass spectrometry (MS) method, use extraction plus a chromatographic step to separate E2 from similar compounds in the serum sample before quantification by MS. Measurements based on MS depend upon the accuracy of calibration, freedom from interference, and appropriateness of any analytical corrections.

The author recommend the development of a universally recognized estradiol standard to which all measurements can be traced and of estradiol reference ranges specific for age, gender and stage of reproductive development. A wider recognition among physicians, laboratory staff that low estradiol values in men, children, and menopausal women obtained using current clinical testing methods are likely to be untrustworthy. New methods should be created capable of accurately and precisely measuring small concentrations of estradiol in routine clinical specimens.

William Rosner, MD, the lead author of the study, said, "Estradiol levels need to be accurately, precisely and consistently measured to provide the proper care for patients from the cradle to the grave. Health care providers rely on estradiol testing to diagnose and help treat a variety of conditions, including infertility, osteoporosis, and breast cancer. Current testing methods need to evolve to meet patients' needs.” The study was published on March 5, 2013, in the Journal of Clinical Endocrinology and Metabolism.

Related Links:

The Endocrine Society




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.